Human Chorionic Gonadotropin (HCG) Market Size - North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, Canada - Trends and Forecast Report 2024-2028

Human Chorionic Gonadotropin Market Size 2024-2028

The human chorionic gonadotropin market size is forecast to increase by USD 193.8 million at a CAGR of 4.5% between 2023 and 2028.

• The HCG market is experiencing significant growth due to several key factors. The prevalence of infertility continues to rise, driving demand for fertility services that utilize HCG. Moreover, an emerging trend of delayed pregnancies among women, particularly in developed regions, is contributing to market expansion.
• Additionally, the presence of alternative procedures for fertility treatment, such as in vitro fertilization (IVF) and intrauterine insemination (IUI), further boosts the market. These trends underscore the importance of HCG in addressing reproductive health needs and improving overall patient outcomes.

What will be the Size of the Human Chorionic Gonadotropin Market During the Forecast Period?

Request Free Sample

• The Human Chorionic Gonadotropin (hCG) market encompasses the production and distribution of this essential hormone, which plays a crucial role in pregnancy and reproductive health. HCG is produced by the placenta after conception and helps maintaIn the corpus luteum, which in turn produces essential hormones like progesterone and estrogen to support the uterine lining and nurture the embryo during the first trimester. HCG levels are typically monitored by healthcare providers through blood or urine tests during pregnancy to assess fetal health and monitor progress. HCG is also used in various reproductive treatments such as In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) to stimulate ovulation and support follicular development.
• HCG is also used In the diagnosis and management of conditions like infertility, ovulation disorders, and certain congenital disorders. HCG levels can indicate the presence of pregnancy, even before a missed period, making it a critical component in at-home pregnancy tests. Additionally, HCG is used in the treatment of testosterone deficiency, undescended testicles, and certain reproductive disorders in men, in addition to assisted reproductive technology (ART). HCG levels can also be affected by conditions like blighted ovum, miscarriage, ectopic pregnancy, and other complications.

How is this Human Chorionic Gonadotropin Industry segmented and which is the largest segment?

The human chorionic gonadotropin (hcg ) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Technology
  • Natural source extraction
  • Recombinant technology
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
  • Rest of World (ROW)

By Technology Insights

• The natural source extraction segment is estimated to witness significant growth during the forecast period.

Human Chorionic Gonadotropin (HCG), a hormone produced by the syncytiotrophoblast In the human placenta, can be extracted from pregnant women's urine. HCG is also found in purified human menopausal gonadotropin (hMG), a natural product derived from postmenopausal women's urine, which contains follicle-stimulating hormone (FSH), luteinizing hormone (LH), and a small amount of HCG. The HCG utilized in in-vitro fertilization (IVF) is sourced from pregnant women's urine and contains additional proteins. The expanding accessibility of infertility treatment devices, coupled with the increasing prevalence of hypogonadism-related disorders in men, particularly in older adults, is fueling the global demand for HCG. This hormone plays a crucial role in pregnancy, including supporting the uterine lining, embryo implantation, and maintaining pregnancy throughout the trimesters.

Healthcare providers use HCG levels to monitor pregnancy progress, often through blood or urine tests, including at-home pregnancy tests. Low HCG levels may indicate complications, such as a blighted ovum, miscarriage, or ectopic pregnancy, while high levels can indicate a healthy pregnancy. It's essential to note that HCG levels fluctuate throughout pregnancy, with double peaks during the first and second trimesters, followed by a decline during the remainder of the pregnancy. Caution is necessary when interpreting HCG test results, as false negatives or positives can occur. Ultrasound is often used to confirm pregnancy diagnosis when HCG levels are ambiguous.

Get a glance at the Human Chorionic Gonadotropin (HCG ) Industry report of share of various segments Request Free Sample

The Natural source extraction segment was valued at USD 451.90 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• Asia is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The Human Chorionic Gonadotropin (HCG) market in North America is experiencing growth due to the increasing prevalence of infertility in the US population. Approximately 6.7 million Americans face infertility issues each year, according to Fertility Answers, a leading fertility care center In the US. This trend, coupled with heightened awareness and accessibility of infertility treatments, is driving market expansion. HCG, a pregnancy hormone produced by the placenta after conception, plays a crucial role in maintaining the corpus luteum during early pregnancy and stimulating the production of estrogen and progesterone. Its application in women's health therapeutics and infertility treatments, including in-vitro fertilization (IVF) and intrauterine insemination (IUI), further bolsters market growth.

HCG levels are monitored during pregnancy to assess the health of the embryo and the uterine wall, and to diagnose conditions such as blighted ovum, miscarriage, ectopic pregnancy, and congenital disorders. Healthcare providers use blood tests and urine tests, including at-home pregnancy tests, to measure HCG levels. While normal pregnancy hormone levels indicate a healthy baby, low HCG levels may necessitate further testing, such as ultrasound, for accurate diagnosis.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise In the adoption of Human Chorionic Gonadotropin Industry?

Increase in prevalence of infertility is the key driver of the market.

• HCG, or Human Chorionic Gonadotropin, is a hormone produced by the placenta during pregnancy. This hormone plays a crucial role in maintaining the pregnancy by supporting the embryo's implantation and the development of the uterine lining. HCG levels increase after conception and peak during the first trimester, remaining elevated throughout pregnancy. Healthcare providers often use blood or urine tests to detect HCG levels to diagnose pregnancy, especially in cases of irregular menstruation or suspected infertility. During infertility treatment, such as IVF (in-vitro fertilization) or IUI (intrauterine insemination), HCG is used to stimulate ovulation and support the luteal phase. HCG levels can also indicate the health of the pregnancy, with low levels potentially indicating a blighted ovum, miscarriage, or ectopic pregnancy.
• A negative HCG test result may indicate that a pregnancy is not viable, while a positive result confirms pregnancy. HCG levels can also be used to monitor the progression of a healthy pregnancy, with ultrasounds providing additional diagnostic information. However, caution is necessary when interpreting HCG levels, as levels can vary from woman to woman and may not always correlate with the health of the pregnancy. Multiple testings and single readings may be necessary for accurate diagnosis. HCG is essential for the development of the embryo and the thickening of the uterine wall during pregnancy. Imbalances in HCG levels can lead to complications, such as congenital disorders or miscarriage.
• HCG levels decline towards the end of pregnancy and remain low during the remainder of the pregnancy, indicating the normal progression of a healthy pregnancy.

What are the market trends shaping the HCG Industry?

Emerging trend of delayed pregnancies among women is the upcoming market trend.

• The Human Chorionic Gonadotropin (HCG) market is significantly influenced by the hormone's role during pregnancy. HCG, produced by the placenta after conception, helps maintaIn the corpus luteum, which in turn secretes essential pregnancy hormones, such as estrogen and progesterone, to support the uterine lining and the embryo's growth. HCG levels increase during pregnancy, peaking around the first trimester, and then declining as the pregnancy progresses. Healthcare providers often use HCG blood or urine tests to diagnose pregnancy, particularly during the early stages. At-home pregnancy tests detect HCG levels in urine. Low HCG levels may indicate a blighted ovum, miscarriage, or ectopic pregnancy, while normal levels indicate a healthy pregnancy.
• However, a single negative test result does not necessarily rule out pregnancy, as HCG levels can be too low for detection at the time of testing. Retesting is often necessary for accurate diagnosis. IVF and IUI treatments also use HCG to trigger ovulation and monitor the development of the follicle and the thickness of the uterine wall. HCG levels are crucial indicators of the success of these treatments. Infertility, caused by factors such as undescended testicles, sperm abnormalities, and ovulation disorders, increases the demand for HCG treatments. However, caution is necessary when interpreting HCG test results, as levels can vary widely depending on the individual's health and the stage of pregnancy.
• Multiple testings may be necessary for accurate diagnosis and monitoring. Ultrasound is often used in conjunction with HCG testing to diagnose pregnancy and monitor fetal development. HCG levels remain important indicators throughout pregnancy, with double peaks sometimes observed during the second trimester. Proper monitoring and interpretation of HCG levels are essential for ensuring a healthy pregnancy and delivering a healthy baby.

What challenges does the Human Chorionic Gonadotropin Industry face during its growth?

Presence of alternative procedures for fertility treatment is a key challenge affecting the industry growth.

• The Human Chorionic Gonadotropin (HCG) market In the healthcare sector is centered around the use of this hormone during pregnancy. Produced by the placenta after conception, HCG plays a crucial role in maintaining the corpus luteum, which in turn supports the uterine lining and the embryo's development during the first trimester. HCG levels peak around the time of ovulation and then decline as the pregnancy progresses, with the remainder of pregnancy relying on the hormones Estrogen and Progesterone. HCG is typically measured through blood or urine tests, with at-home pregnancy tests detecting HCG levels in urine. Low HCG levels may indicate a blighted ovum, miscarriage, or ectopic pregnancy, while high levels can indicate a healthy pregnancy.
• However, a single reading may not always provide a definitive diagnosis, and healthcare providers may recommend multiple testings or transvaginal ultrasounds for a more accurate diagnosis. HCG has various applications beyond pregnancy, including ovulation induction and testosterone therapy for men with undescended testicles or other congenital disorders. However, the market for HCG is facing challenges due to the emergence of alternative procedures for fertility treatment and weight management. Assisted reproductive technologies (ART) such as IVF and IUI have gained popularity due to their higher success rates and perceived invasiveness compared to HCG therapy. Additionally, weight management approaches like lifestyle modifications, dietary changes, and newer pharmaceutical options have gained traction, reducing the demand for HCG in this application.
• It is essential for individuals considering HCG therapy to consult with their healthcare provider for accurate information and guidance, as HCG levels can vary widely depending on individual circumstances. Caution should be exercised when interpreting HCG test results, as false positives and false negatives can occur, and multiple readings may be necessary for a definitive diagnosis.

Exclusive Customer Landscape

The human chorionic gonadotropin market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the HCG market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, human chorionic gonadotropin market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Ferring BV
• Fresenius Kabi AG
• Intas Pharmaceuticals Ltd.
• Lee BioSolutions Inc
• Lupin Ltd.
• Merck and Co. Inc.
• Sanzyme Pvt. Ltd.
• Serum Institute of India Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• The Cigna Group

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Human Chorionic Gonadotropin (hCG) is a vital hormone produced during pregnancy, primarily by the placenta. This hormone plays a crucial role in maintaining the pregnancy by stimulating the production of progesterone, which is essential for the development of the embryo and the thickening of the uterine lining. The hCG market encompasses various applications, including diagnostic and therapeutic uses. In the diagnostic arena, hCG is utilized to confirm pregnancy and monitor its progression. HCG tests are available in various formats, including blood tests, urine tests, and at-home pregnancy tests. These tests provide valuable insights into hCG levels, which can help healthcare providers assess the health of the pregnancy and identify potential complications.

HCG levels undergo distinct patterns during pregnancy. Initially, hCG levels rise rapidly, peaking around the 10th week, and then begin to decline as the pregnancy progresses. The remainder of the pregnancy is characterized by relatively stable hCG levels. However, caution is warranted when interpreting hCG test results, as hCG levels can be influenced by various factors, including multiple pregnancies, ectopic pregnancies, and miscarriages. HCG testing is a critical tool for healthcare providers in managing pregnancies, particularly in cases of infertility, where ovulation induction and assisted reproductive technologies, such as In-Vitro Fertilization (IVF) and Intrauterine Insemination (IUI), are employed.

HCG testing is also used to monitor ovulation and assess the success of these treatments. The hCG market is driven by several factors, including the increasing prevalence of infertility and the growing demand for accurate and reliable pregnancy tests. Additionally, advancements in hCG testing technology, such as digital hCG tests and point-of-care tests, are contributing to the market's growth. Despite the benefits of hCG testing, there are challenges associated with its use. For instance, hCG levels can be influenced by various factors, leading to false-positive or false-negative results. Additionally, hCG testing can be costly, particularly for repeated tests, which may be necessary to confirm a pregnancy or monitor its progression.

In conclusion, the HCG market plays a vital role In the diagnosis and management of pregnancy. HCG testing provides valuable insights into the health of the pregnancy and helps healthcare providers identify potential complications. The market is driven by several factors, including the increasing prevalence of infertility and advancements in HCG testing technology. However, challenges associated with hCG testing, such as false-positive and false-negative results and cost, must be addressed to ensure accurate and reliable pregnancy testing.

Request Free Sample

What are the Key Data Covered in this Human Chorionic Gonadotropin Market Research and Growth Report?

• CAGR of the HCG industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the human chorionic gonadotropin market growth of industry companies

We can help! Our analysts can customize this HCG market research report to meet your requirements.

Get in touch